Physician profile
John Luck
NPI 1619332475
$14,436.73
in general payments reported to CMS, 2019-2025
17 companies · $2,574 in 2025
The $2,574 reported for 2025 was more than what 84% of Surgery providers received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $85.92 · 2020: $73.08 · 2021: $2,303 · 2022: $549 · 2023: $3,274 · 2024: $5,578 · 2025: $2,574.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $6,134 · Food and Beverage: $5,292.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $6,134.12 |
| Food and Beverage | $5,292.02 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $6,803.10 | 2023-2025 | |
| Allergan, INC. | $1,879.31 | 2021 | |
| Baxter Healthcare | $1,656.72 | 2020-2025 | Artiss, Floseal, Tisseel |
| Stryker Corporation | $1,411.98 | 2025 | Na |
| Depuy Synthes Sales INC. | $1,187.70 | 2022-2025 | Trumatch, Cementralizer, Matrixneuro |
| Integra Lifesciences Corporation | $452.68 | 2022-2024 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Davol INC. | $163.34 | 2022 | |
| Axogen | $160.84 | 2024 | Axoguard Nerve Protector, Axoguard Ha+ Nerve Protector, Axoguard Nerve Cap |
| Tela Bio, INC. | $158.38 | 2023 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Ethicon US, LLC | $105.00 | 2025 | Vistaseal, Stratafix, Dermabond |
| Becton, Dickinson and Company | $94.50 | 2024 | Phasix Mesh |
| Exsomed Corporation | $93.15 | 2021 | |
| Motiva USA, LLC | $92.34 | 2025 | |
| Tepha INC | $85.92 | 2019 | |
| Mentor Worldwide LLC | $45.21 | 2025 | Mentor Memorygel Resterilizable Gel Sizer |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $31.69 | 2025 | Stravix Pl |
| Coopersurgical, INC. | $14.87 | 2025 | Onetrac Lx |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Luck listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.